Danyelza
Product Images NDC 73042-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Danyelza (NDC 73042-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Y-mabs Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (40 mg/10 mL Vial Carton)

Principal Display Panel (40 mg/10 mL Vial Carton)
DANVELZA is an injection of naxitamab-gqgk in a single-dose vial. The vial contains 40mg/0mL (4mg/mL) of the drug. Unused portions of the medication should be discarded. The recommended dosage is not specified and the storage temperature should be between 2° to 8°C. The drug is produced by mAbs Therapeutics Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.